This application is for a five year renewal of an institutional training grant titled """"""""Research Training in Neuro-Oncology,"""""""" now in its fifteenth year. This training program is designed to prepare neurosurgeons, neurologists, and medical, pediatric, and radiation oncologists for academic careers in neuro-oncology. Applicants with M.D. degrees who have completed at least one year of postdoctoral training toward board certification in their subspecialty and are committed to a career in academic neuro-oncology are candidates for this research fellowship. Each year, two new trainees are provided with a unique two year program that consists of: 1) Laboratory research under the supervision of an experienced scientist at the Johns Hopkins Medical Institutions or the National Institutes of Health; 2) Close interaction with a mentor with peer-reviewed funding in cancer research; 3) A didactic curriculum that includes biostatistics, epidemiology, clinical and laboratory research methods, biomedical writing, neuroanatomy, responsible conduct of research, and an overview of cancer research; 4) Clinical rotations with distinguished clinician scientists; and 5) Participation in neuro-oncology and basic and clinical cancer research conferences at Johns Hopkins and the NIH. The program benefits from a stable, cohesive, and productive faculty with an exemplary track record of training academic neuro-oncologists, a close liaison with multiple departments and disciplines within the Johns Hopkins Medical Institutions and the National Institutes of Health, a multi-disciplinary approach to training as exemplified by the diversity of the faculty, and active clinical and basic science research focused on neuro-oncology. This program is designed to provide well-rounded research training to trainees and to develop them as the next generation of investigators in neuro-oncology.
| Blakeley, Jaishri O; Grossman, Stuart A; Chi, Andrew S et al. (2018) Phase II Study of Iniparib with Concurrent Chemoradiation in Patients with Newly Diagnosed Glioblastoma. Clin Cancer Res : |
| Yovino, Susannah; Grossman, Stuart A (2012) Severity, etiology and possible consequences of treatment-related lymphopenia in patients with newly diagnosed high-grade gliomas. CNS Oncol 1:149-54 |
| Chesler, David A; Berger, Mitchell S; Quinones-Hinojosa, Alfredo (2012) The potential origin of glioblastoma initiating cells. Front Biosci (Schol Ed) 4:190-205 |
| Agrawal, Nishant; Frederick, Mitchell J; Pickering, Curtis R et al. (2011) Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 333:1154-7 |
| Chesler, D A; Pendleton, C; Jallo, G I et al. (2011) ""Colossal"" breakthrough: the callosal puncture as a precursor to third ventriculostomy. Minim Invasive Neurosurg 54:243-6 |
| Bettegowda, Chetan; Agrawal, Nishant; Jiao, Yuchen et al. (2011) Mutations in CIC and FUBP1 contribute to human oligodendroglioma. Science 333:1453-5 |
| Hsu, Wesley; Dorsi, Michael J; Witham, Timothy F (2009) Surgical Management of Cervical Spondylotic Myelopathy. Neurosurg Q 19:302-307 |
| Pradilla, Gustavo; Wang, Paul P; Gabikian, Patrik et al. (2006) Local intracerebral administration of Paclitaxel with the paclimer delivery system: toxicity study in a canine model. J Neurooncol 76:131-8 |
| Stearns, Duncan; Chaudhry, Aneeka; Abel, Ty W et al. (2006) c-myc overexpression causes anaplasia in medulloblastoma. Cancer Res 66:673-81 |
| Sampath, Prakash; Amundson, Eric; Wall, Monroe E et al. (2003) Camptothecin analogs in malignant gliomas: comparative analysis and characterization. J Neurosurg 98:570-7 |
Showing the most recent 10 out of 39 publications
